Lista de obras - Kimberly K Leslie - Dominio Público Uruguay

"Collection of a lifetime: a practical approach to developing a longitudinal collection of women's healthcare biological samples".

artículo científico publicado en 2014

A mechanism for synergy with combined mTOR and PI3 kinase inhibitors

artículo científico publicado en 2011

A phase II evaluation of cediranib in the treatment of recurrent or persistent endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study.

artículo científico publicado en 2015

A phase II evaluation of gefitinib in the treatment of persistent or recurrent endometrial cancer: a Gynecologic Oncology Group study

artículo científico publicado en 2013

A phase II evaluation of lapatinib in the treatment of persistent or recurrent epithelial ovarian or primary peritoneal carcinoma: A gynecologic oncology group study ⬇️

artículo científico publicado el 28 de octubre de 2011

A phase II evaluation of nintedanib (BIBF-1120) in the treatment of recurrent or persistent endometrial cancer: an NRG Oncology/Gynecologic Oncology Group Study

artículo científico publicado en 2014

A phase II trial of brivanib in recurrent or persistent endometrial cancer: an NRG Oncology/Gynecologic Oncology Group Study.

artículo científico publicado en 2014

A randomized controlled trial of interleukin-1 receptor antagonist in a rabbit model of ascending infection in pregnancy

artículo científico publicado en 2001

AZD1775 Increases Sensitivity to Olaparib and Gemcitabine in Cancer Cells with p53 Mutations.

artículo científico publicado en 2018

An exploratory study of the variables impacting preterm birth rates in New Mexico

artículo científico publicado en 2012

An inhibitor of K+ channels modulates human endometrial tumor-initiating cells.

artículo científico

BKCa channel inhibitor modulates the tumorigenic ability of hormone-independent breast cancer cells via the Wnt pathway

artículo científico publicado en 2014

Breast cancer and pregnancy

artículo científico publicado en 2005

Cadherins, catenins and cell cycle regulators: Impact on survival in a Gynecologic Oncology Group phase II endometrial cancer trial ⬇️

artículo científico publicado el 3 de agosto de 2011

Chemotherapeutic drugs in pregnancy.

artículo científico publicado en 2005

Chemotherapy and pregnancy

artículo científico publicado en 2002

Chronic hepatitis C in pregnancy

artículo científico publicado en 2008

Combination of Proteasome and Histone Deacetylase Inhibitors Overcomes the Impact of Gain-of-Function p53 Mutations

artículo científico publicado en 2018

Comprehensive profiling of EGFR/HER receptors for personalized treatment of gynecologic cancers

scientific article published on April 2014

Consequences of the loss of p53, RB1, and PTEN: relationship to gefitinib resistance in endometrial cancer.

artículo científico publicado en 2007

Cullin-5, a ubiquitin ligase scaffold protein, is significantly underexpressed in endometrial adenocarcinomas and is a target of miR-182.

artículo científico publicado en 2016

Cytoplasmic Metadherin (MTDH) provides survival advantage under conditions of stress by acting as RNA-binding protein.

artículo científico publicado en 2011

Differential expression of the A and B isoforms of progesterone receptor in human endometrial cancer cells. Only progesterone receptor B is induced by estrogen and associated with strong transcriptional activation

scientific article published on 01 September 1997

Differential gene expression in the amnion, chorion, and trophoblast of the human placenta

artículo científico publicado en 1993

Downregulation of FOXO1 mRNA levels predicts treatment failure in patients with endometrial pathology conservatively managed with progestin-containing intrauterine devices

artículo científico publicado en 2015

Dysregulation of miR-181c expression influences recurrence of endometrial endometrioid adenocarcinoma by modulating NOTCH2 expression: An NRG Oncology/Gynecologic Oncology Group study

artículo científico publicado en 2017

EGFR isoforms and gene regulation in human endometrial cancer cells

artículo científico publicado en 2010

Effect of tamoxifen on endometrial histology, hormone receptors, and cervical cytology: a prospective study with follow-up

scientific article published on 01 September 2007

Effects of bevacizumab in mouse model of endometrial cancer: Defining the molecular basis for resistance.

artículo científico publicado en 2011

Endometrial cancer

artículo científico publicado en 2012

Endometrial cancer: potential treatment and prevention with progestin-containing intrauterine devices

scientific article published on 01 February 2012

Estrogen Receptors Are Identified in the Glioblastoma Cell Line UI38MG ⬇️

artículo científico publicado el 1 de julio de 1994

Estrogens in intrahepatic cholestasis of pregnancy

scientific article published on 01 March 2000

Functional analysis of a mutant estrogen receptor isolated from T47Dco breast cancer cells

artículo científico publicado el 1 de abril de 1992

GPR30: a novel indicator of poor survival for endometrial carcinoma

artículo científico publicado en 2007

Gene regulation profiles by progesterone and dexamethasone in human endometrial cancer Ishikawa H cells.

artículo científico publicado en 2005

Genetic Deficiency of Mtdh Gene in Mice Causes Male Infertility via Impaired Spermatogenesis and Alterations in the Expression of Small Non-coding RNAs.

artículo científico publicado en 2015

Global dysregulation of the chromosome 14q32 imprinted region in uterine carcinosarcoma

artículo científico publicado en 2012

Hepatitis B and C in pregnancy: a review and recommendations for care.

artículo científico publicado en 2014

High stathmin expression is a marker for poor clinical outcome in endometrial cancer: An NRG oncology group/gynecologic oncology group study.

artículo científico publicado en 2017

Histologic effects of medroxyprogesterone acetate on endometrioid endometrial adenocarcinoma: a Gynecologic Oncology Group study.

artículo científico publicado en 2014

Immunomodulatory and transcriptional effects of progesterone through progesterone A and B receptors in Hec50co poorly differentiated endometrial cancer cells.

artículo científico publicado en 2004

Introduction to the American Heart Association's Hypertension Strategically Focused Research Network.

artículo científico publicado en 2016

Inverse Relationship between Progesterone Receptor and Myc in Endometrial Cancer

artículo científico publicado en 2016

Lapatinib and potential prognostic value of EGFR mutations in a Gynecologic Oncology Group phase II trial of persistent or recurrent endometrial cancer

artículo científico publicado en 2012

Linkage of two human pregnancy-specific beta 1-glycoprotein genes: one is associated with hydatidiform mole

artículo científico publicado en 1990

Low Serum Estradiol and High Serum Progesterone Concentrations Characterize Hypertensive Pregnancies at High Altitude ⬇️

artículo científico publicado el 1 de julio de 1994

MicroRNA-31 is significantly elevated in both human endometrium and serum during the window of implantation: a potential biomarker for optimum receptivity.

artículo científico publicado en 2014

Models representing type I and type II human endometrial cancers: Ishikawa H and Hec50co cells.

artículo científico publicado en 2007

Molecular tools to reestablish progestin control of endometrial cancer cell proliferation.

artículo científico publicado en 2001

NEDD4 ubiquitin ligase is a putative oncogene in endometrial cancer that activates IGF-1R/PI3K/Akt signaling

artículo científico publicado en 2015

Oestrogen modulation with parturition in the human placenta

scientific article published on 01 January 1994

Past, present, and future of hormonal therapy in recurrent endometrial cancer

artículo científico publicado en 2014

Phase II Trial of Bevacizumab in Recurrent or Persistent Endometrial Cancer: A Gynecologic Oncology Group Study ⬇️

artículo científico publicado el 2 de mayo de 2011

Placenta-Specific Protein 1 Expression in Human Papillomavirus 16/18-Positive Cervical Cancers Is Associated With Tumor Histology.

artículo científico publicado en 2017

Prediction of chemo-response in serous ovarian cancer

artículo científico publicado en 2016

Pregnancy specific beta 1 glycoprotein (SP-1) in maternal serum and amniotic fluid; pre-eclampsia, small for gestational age fetus and fetal distress

artículo científico publicado en 1993

Progesterone regulation of activating protein-1 transcriptional activity: a possible mechanism of progesterone inhibition of endometrial cancer cell growth.

artículo científico publicado en 2003

Progesterone: the ultimate endometrial tumor suppressor.

artículo científico publicado en 2011

Regulation of signaling phosphoproteins by epidermal growth factor and Iressa (ZD1839) in human endometrial cancer cells that model type I and II tumors.

artículo científico publicado en 2005

Relationship of estrogen and progesterone receptors to clinical outcome in metastatic endometrial carcinoma: a Gynecologic Oncology Group Study

artículo científico publicado en 2007

Role of metadherin in estrogen-regulated gene expression

artículo científico publicado en 2017

Stratification of endometrioid endometrial cancer patients into risk levels using somatic mutations.

artículo científico publicado en 2016

Synthetically lethal nanoparticles for treatment of endometrial cancer.

artículo científico publicado en 2017

TP53 oncomorphic mutations predict resistance to platinum‑ and taxane‑based standard chemotherapy in patients diagnosed with advanced serous ovarian carcinoma.

artículo científico publicado en 2014

Targeted treatment using monoclonal antibodies and tyrosine-kinase inhibitors in pregnancy.

artículo científico publicado en 2007

Temsirolimus with or without megestrol acetate and tamoxifen for endometrial cancer: a gynecologic oncology group study

artículo científico publicado en 2014

The consequence of oncomorphic TP53 mutations in ovarian cancer

artículo científico publicado en 2013

Tumor mutational analysis of GOG248, a phase II study of temsirolimus or temsirolimus and alternating megestrol acetate and tamoxifen for advanced endometrial cancer (EC): An NRG Oncology/Gynecologic Oncology Group study

artículo científico publicado en 2016

Vasopressin in preeclampsia: a novel very early human pregnancy biomarker and clinically relevant mouse model

artículo científico publicado en 2014

miR-888: A Novel Cancer-Testis Antigen that Targets the Progesterone Receptor in Endometrial Cancer

artículo científico publicado en 2015

microRNA expression profiling of endometrial endometrioid adenocarcinomas and serous adenocarcinomas reveals profiles containing shared, unique and differentiating groups of microRNAs

artículo científico publicado en 2011

p53 mutation status is a primary determinant of placenta-specific protein 1 expression in serous ovarian cancers

artículo científico publicado en 2017

Lista de obras de Kimberly K Leslie

"Collection of a lifetime: a practical approach to developing a longitudinal collection of women's healthcare biological samples".

A mechanism for synergy with combined mTOR and PI3 kinase inhibitors

A phase II evaluation of cediranib in the treatment of recurrent or persistent endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study.

A phase II evaluation of gefitinib in the treatment of persistent or recurrent endometrial cancer: a Gynecologic Oncology Group study

A phase II evaluation of lapatinib in the treatment of persistent or recurrent epithelial ovarian or primary peritoneal carcinoma: A gynecologic oncology group study ⬇️

A phase II evaluation of nintedanib (BIBF-1120) in the treatment of recurrent or persistent endometrial cancer: an NRG Oncology/Gynecologic Oncology Group Study

A phase II trial of brivanib in recurrent or persistent endometrial cancer: an NRG Oncology/Gynecologic Oncology Group Study.

A randomized controlled trial of interleukin-1 receptor antagonist in a rabbit model of ascending infection in pregnancy

AZD1775 Increases Sensitivity to Olaparib and Gemcitabine in Cancer Cells with p53 Mutations.

An exploratory study of the variables impacting preterm birth rates in New Mexico

An inhibitor of K+ channels modulates human endometrial tumor-initiating cells.

BKCa channel inhibitor modulates the tumorigenic ability of hormone-independent breast cancer cells via the Wnt pathway

Breast cancer and pregnancy

Cadherins, catenins and cell cycle regulators: Impact on survival in a Gynecologic Oncology Group phase II endometrial cancer trial ⬇️

Chemotherapeutic drugs in pregnancy.

Chemotherapy and pregnancy

Chronic hepatitis C in pregnancy

Combination of Proteasome and Histone Deacetylase Inhibitors Overcomes the Impact of Gain-of-Function p53 Mutations

Comprehensive profiling of EGFR/HER receptors for personalized treatment of gynecologic cancers

Consequences of the loss of p53, RB1, and PTEN: relationship to gefitinib resistance in endometrial cancer.

Cullin-5, a ubiquitin ligase scaffold protein, is significantly underexpressed in endometrial adenocarcinomas and is a target of miR-182.

Cytoplasmic Metadherin (MTDH) provides survival advantage under conditions of stress by acting as RNA-binding protein.

Differential expression of the A and B isoforms of progesterone receptor in human endometrial cancer cells. Only progesterone receptor B is induced by estrogen and associated with strong transcriptional activation

Differential gene expression in the amnion, chorion, and trophoblast of the human placenta

Downregulation of FOXO1 mRNA levels predicts treatment failure in patients with endometrial pathology conservatively managed with progestin-containing intrauterine devices

Dysregulation of miR-181c expression influences recurrence of endometrial endometrioid adenocarcinoma by modulating NOTCH2 expression: An NRG Oncology/Gynecologic Oncology Group study

EGFR isoforms and gene regulation in human endometrial cancer cells

Effect of tamoxifen on endometrial histology, hormone receptors, and cervical cytology: a prospective study with follow-up

Effects of bevacizumab in mouse model of endometrial cancer: Defining the molecular basis for resistance.

Endometrial cancer

Endometrial cancer: potential treatment and prevention with progestin-containing intrauterine devices

Estrogen Receptors Are Identified in the Glioblastoma Cell Line UI38MG ⬇️

Estrogens in intrahepatic cholestasis of pregnancy

Functional analysis of a mutant estrogen receptor isolated from T47Dco breast cancer cells

GPR30: a novel indicator of poor survival for endometrial carcinoma

Gene regulation profiles by progesterone and dexamethasone in human endometrial cancer Ishikawa H cells.

Genetic Deficiency of Mtdh Gene in Mice Causes Male Infertility via Impaired Spermatogenesis and Alterations in the Expression of Small Non-coding RNAs.

Global dysregulation of the chromosome 14q32 imprinted region in uterine carcinosarcoma

Hepatitis B and C in pregnancy: a review and recommendations for care.

High stathmin expression is a marker for poor clinical outcome in endometrial cancer: An NRG oncology group/gynecologic oncology group study.

Histologic effects of medroxyprogesterone acetate on endometrioid endometrial adenocarcinoma: a Gynecologic Oncology Group study.

Immunomodulatory and transcriptional effects of progesterone through progesterone A and B receptors in Hec50co poorly differentiated endometrial cancer cells.

Introduction to the American Heart Association's Hypertension Strategically Focused Research Network.

Inverse Relationship between Progesterone Receptor and Myc in Endometrial Cancer

Lapatinib and potential prognostic value of EGFR mutations in a Gynecologic Oncology Group phase II trial of persistent or recurrent endometrial cancer

Linkage of two human pregnancy-specific beta 1-glycoprotein genes: one is associated with hydatidiform mole

Low Serum Estradiol and High Serum Progesterone Concentrations Characterize Hypertensive Pregnancies at High Altitude ⬇️

MicroRNA-31 is significantly elevated in both human endometrium and serum during the window of implantation: a potential biomarker for optimum receptivity.

Models representing type I and type II human endometrial cancers: Ishikawa H and Hec50co cells.

Molecular tools to reestablish progestin control of endometrial cancer cell proliferation.

NEDD4 ubiquitin ligase is a putative oncogene in endometrial cancer that activates IGF-1R/PI3K/Akt signaling

Oestrogen modulation with parturition in the human placenta

Past, present, and future of hormonal therapy in recurrent endometrial cancer

Phase II Trial of Bevacizumab in Recurrent or Persistent Endometrial Cancer: A Gynecologic Oncology Group Study ⬇️

Placenta-Specific Protein 1 Expression in Human Papillomavirus 16/18-Positive Cervical Cancers Is Associated With Tumor Histology.

Prediction of chemo-response in serous ovarian cancer

Pregnancy specific beta 1 glycoprotein (SP-1) in maternal serum and amniotic fluid; pre-eclampsia, small for gestational age fetus and fetal distress

Progesterone regulation of activating protein-1 transcriptional activity: a possible mechanism of progesterone inhibition of endometrial cancer cell growth.

Progesterone: the ultimate endometrial tumor suppressor.

Regulation of signaling phosphoproteins by epidermal growth factor and Iressa (ZD1839) in human endometrial cancer cells that model type I and II tumors.

Relationship of estrogen and progesterone receptors to clinical outcome in metastatic endometrial carcinoma: a Gynecologic Oncology Group Study

Role of metadherin in estrogen-regulated gene expression

Stratification of endometrioid endometrial cancer patients into risk levels using somatic mutations.

Synthetically lethal nanoparticles for treatment of endometrial cancer.

TP53 oncomorphic mutations predict resistance to platinum‑ and taxane‑based standard chemotherapy in patients diagnosed with advanced serous ovarian carcinoma.

Targeted treatment using monoclonal antibodies and tyrosine-kinase inhibitors in pregnancy.

Temsirolimus with or without megestrol acetate and tamoxifen for endometrial cancer: a gynecologic oncology group study

The consequence of oncomorphic TP53 mutations in ovarian cancer

Tumor mutational analysis of GOG248, a phase II study of temsirolimus or temsirolimus and alternating megestrol acetate and tamoxifen for advanced endometrial cancer (EC): An NRG Oncology/Gynecologic Oncology Group study

Vasopressin in preeclampsia: a novel very early human pregnancy biomarker and clinically relevant mouse model

miR-888: A Novel Cancer-Testis Antigen that Targets the Progesterone Receptor in Endometrial Cancer

microRNA expression profiling of endometrial endometrioid adenocarcinomas and serous adenocarcinomas reveals profiles containing shared, unique and differentiating groups of microRNAs

p53 mutation status is a primary determinant of placenta-specific protein 1 expression in serous ovarian cancers